AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including AML-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2alphaB). In vitro studies and findings in human diseases, including leukemias, myelodysplastic syndromes and familial platelet disorder with predisposition to acute myeloid leukemia (AML), suggest that AML-1 has a pivotal role in adult hematopoiesis. However, this role has not been fully uncovered in vivo because of the embryonic lethality of Runx1 knockout in mice. Here we assess the requirement of AML-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method. In the absence of AML-1, hematopoietic progenitors were fully maintained with normal myeloid cell development. However, AML-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development. AML-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (HSCs) in adult hematopoiesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“Conditional knockout studies of mice demonstrate a specific role for RUNX-1 in megakaryocyte differentiation during adult stages of hematopoiesis”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“RUNX-1-deficient megakaryocytes have hypolobulated nuclei, underdeveloped cytoplasm, low DNA ploidy, and enhanced replating activity in semisolid medium culture assays.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
Citations
Cites
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“1b ), the cells defined by Lin −/lo IL-7Rα + Sca-1 lo c-Kit lo , previously reported to include common lymphocyte progenitors (CLPs”
BackgroundLong-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641 · cited 1×
“Here we assess the requirement of AML-1/ Runx1 in adult hematopoiesis using an inducible gene-targeting metho”
MethodWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“In vitro studies and findings in human diseases, including leukemia”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
North, T. E., de Bruijn, M. F. T. R., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E., & Speck, N. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00296-0 · Cited by 583
Cited by
Items 301–400 of 595
Jalagadugula, G. S., Mao, G., Kaur, G., Dhanasekaran, D. N., & Rao, A. K. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221879 · Cited by 35
Runx1 Structure and Function in Blood Cell Development
Bonifer, C., Levantini, E., Kouskoff, V., & Lacaud, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_5 · Cited by 31
The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors
Su, J., Wang, X., Bai, Y., Sun, M., Yao, Y., & Duan, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105930 · Cited by 31
Okumura, A. J., Peterson, L. F., Lo, M., & Zhang, D. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.002 · Cited by 34
ter Elst, A., Ma, B., Scherpen, F. J. G., de Jonge, H. J. M., Douwes, J., Wierenga, A. T. J., Schuringa, J. J., Kamps, W. A., & de Bont, E. S. J. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0402 · Cited by 30
“knockout models have suggested that AML1/RUNX1 is not strictly required for steady-state HSC maintenance during adult hematopoiesis (28).”
BackgroundMyeloid neoplasms with germ line RUNX1 mutation
Hayashi, Y., Harada, Y., Huang, G., & Harada, H. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2258-5 · Cited by 35
“On the other hand, Runx1 haploinsufficiency does not generate observable phenotypes in the megakaryocytes and platelets [29, 52], while Runx1 homozygous deletion results in thrombocytopenia in mice [4, 5].”
BackgroundGlembotsky, A. C., Sliwa, D., Bluteau, D., Balayn, N., Oyarzún, C. P. M., Raimbault, A., Bordas, M., Droin, N. M., Pirozhkova, I., Washington, A. V., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.188904 · Cited by 30
“Conditional RUNX1 inactivation in mice leads to MK maturation arrest and a substantial decline in platelet counts, highlighting the key role of RUNX1 as a master regulator of the MK lineage.(4) Germline RUNX1 mutations in humans underlie familial platelet disorder with predisposition to acute myelogenous leukemia (FPD…”
BackgroundCammenga, J., Niebuhr, B., Horn, S., Bergholz, U., Putz, G., Buchholz, F., Löhler, J., & Stocking, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1903 · Cited by 32
Mechanism of ETV6-RUNX1 Leukemia
Sundaresh, A., & Williams, O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_13 · Cited by 30
Kuo, Y., Gerstein, R. M., & Castilla, L. H. (2007) · Blood · doi:10.1182/blood-2007-07-104422 · Cited by 28
Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos
Maki, K., Yamagata, T., Asai, T., Yamazaki, I., Oda, H., Hirai, H., & Mitani, K. (2005) · Blood · doi:10.1182/blood-2004-11-4330 · Cited by 31
Self-citationChisholm, K. M., Denton, C. C., Keel, S., Geddis, A. E., Xu, M., Appel, B., Cantor, A. B., Fleming, M. D., & Shimamura, A. (2019) · Pediatric and Developmental Pathology · doi:10.1177/1093526618822108 · Cited by 32
“In addition, RUNX1 hematopoietic conditional knockout mice have been found to demonstrate small and micro-megakaryocytes.(48) The review of so many marrows with nonclonal karyotypes is one of the strengths of this study, as we can appreciate the morphologic changes that may be due to the RUNX1 germline mutation itself.”
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective
Hayashi, Y., Harada, Y., & Harada, H. (2022) · Leukemia · doi:10.1038/s41375-022-01548-7 · Cited by 31
“Conditional deletion of Runx1 with Mx1-Cre in adult mice does not present a lethal phenotype [26].”
BackgroundResultInfluentialToscano, M. G., Navarro-Montero, Ó., Ayllón, V., Ramos–Mejía, V., Guerrero-Carreno, X., Bueno, C., Romero, T., Lamolda, M., Cobo, M., Martín, F., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.196 · Cited by 30
RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT–enhancer binding protein α function
Tokita, K., Maki, K., & Mitani, K. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00597.x · Cited by 35
Self-citationPR-Set7 Establishes a Repressive trans-Tail Histone Code That Regulates Differentiation
Sims, J. K., & Rice, J. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00410-08 · Cited by 38
“Increased RUNX1 is critical during early stages of megakaryocytic differentiation as megakaryopoiesis fails to initiate without RUNX1 (13, 26).”
BackgroundInfluentialTober, J. M., Maijenburg, M. W., & Speck, N. A. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.01.008 · Cited by 31
Cell-Autonomous Function of Runx1 Transcriptionally Regulates Mouse Megakaryocytic Maturation
Pencovich, N., Jaschek, R., Dicken, J., Amit, A. S., Lotem, J., Tanay, A., & Groner, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064248 · Cited by 31
“Moreover, Runx1 deficiency in adult bone marrow attenuated megakaryocytic maturation and reduced blood platelet numbers (thrombocytopenia) [5].”
BackgroundInfluentialWong, W. F., Nakazato, M., Watanabe, T., Kohu, K., Ogata, T., Yoshida, N., Sotomaru, Y., Ito, M., Araki, K., Telfer, J. C., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03230.x · Cited by 31
Chromatin regulation by AML1 complex
Yoshida, H., & Kitabayashi, I. (2007) · International Journal of Hematology · doi:10.1007/s12185-007-0004-0 · Cited by 32
“AML1 is also required for differentiation of megakaryocytes and lymphocytes [ 10 ].”
BackgroundSood, R. B., & Liu, P. (2012) · Advances in Hematology · doi:10.1155/2012/830703 · Cited by 28
“Conditional knockout mice were able to develop all lineages but showed defects in megakaryocyte maturation and differentiation of B and T cells [133, 134].”
BackgroundBonifer, C., & Bowen, D. T. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001377 · Cited by 26
“63 Ichikawa, M. et al. (2004) AML-1 is required for megakaryocytic maturation and lymphocytic”
BackgroundRegulation of RUNX1/AML1 during the G2/M transition
Wang, S., Zhang, Y., Soosairajah, J., & Kraft, A. S. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.08.016 · Cited by 34
Kawazu, M., Yamamoto, G., Yoshimi, M., Yamamoto, K. Z., Asai, T., Ichikawa, M., Seo, S., Nakagawa, M. M., Chiba, S., Kurokawa, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5335 · Cited by 29
“blocked in Runx1-deficinet mice (18, 19) and also in double knock-”
BackgroundSelf-citationGenetic compensation of RUNX family transcription factors in leukemia
Kamikubo, Y. (2018) · Cancer Science · doi:10.1111/cas.13664 · Cited by 30
“influenced in the conditional knockout mouse, although slight change was noted in platelets, suggesting that RUNX1 is not essential for hematopoiesis in adults.(8) It has been regarded as a tumor suppressor because mutation and chromosomal translocation of RUNX1 are observed in leukemia at a high rate, but this classi…”
BackgroundPina, C., & Enver, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210759 · Cited by 39
“As is the case for SCL, analysis of conditional knockout mice (Ichikawa et al., 2004) revealed that RUNX1 is dispensable for maintenance of a functional HSC compartment in adult BM.”
Understanding and Modulating Immunity With Cell Reprogramming
Pires, C. F., Rosa, F. A., Kurochkin, I., & Pereira, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02809 · Cited by 30
“RUNX1 expression is essential for HSPC specification in the embryo (131), but is no longer required for maintaining HSPCs in the adult (132).”
BackgroundRUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
Cieślak, A., Noir, S. L., Trinquand, A., Lhermitte, L., Franchini, D., Villarèse, P., Gon, S., Bond, J., Simonin, M., Vanhille, L., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132585 · Cited by 30
“In adult mice, inactivation of Runx1 impairs lymphoid and megakaryocyte lineage maturation (Ichikawa et al., 2004; Growney et al., 2005) and leads to HSC exhaustion, although this is still under debate ( Jacob et al., 2010; Cai et al., 2011).”
BackgroundCBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice
Cai, Q., Jeannet, R., Hua, W.-K., Cook, G., Zhang, B., Qi, J., Liu, H., Li, L., Chen, C., Marcucci, G., et al. (2016) · Blood · doi:10.1182/blood-2016-01-693119 · Cited by 26
“These defects are presumably due to Runx1 inhibition because similar deficiencies were seen in Runx1-deficient mice.(28,29) Previous studies also noted that CM expression affected primitive erythropoiesis; however, CM knocked-in cells were detected in the c-kit(1)/Ter119(1) BM population in CM knock-in chimeras.”
Fuhrken, P. G., Chen, C., Apostolidis, P. A., Wang, M., Miller, W. M., & Papoutsakis, E. T. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00127.2007 · Cited by 27
“Later, committed Mk progenitors turn into early-maturing megakaryocytes, with positive regulation by RUNX1, TEL, GATA1, and NFE2 (25, 27 , 52).”
BackgroundMyelodysplastic Syndromes (MDS)
Pleyer, L., Neureiter, D., Faber, V., & Greil, R. (2010) · Springer eBooks · doi:10.1007/978-3-211-79892-8_6 · Cited by 25
Shared roles for Scl and Lyl1 in murine platelet production and function
Chiu, S. K., Orive, S. L., Moon, M. J., Saw, J., Ellis, S. L., Kile, B. T., Huang, Y., Fajardo, D. C., Pimanda, J. E., Beck, D., et al. (2019) · Blood · doi:10.1182/blood.2019896175 · Cited by 35
Yoshimi, M., Goyama, S., Kawazu, M., Nakagawa, M. M., Ichikawa, M., Imai, Y., Kumano, K., Asai, T., Mulloy, J. C., Kraft, A. S., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201040746 · Cited by 24
Self-citationLichtinger, M., Hoogenkamp, M., Krysinska, H., Ingram, R., & Bonifer, C. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.02.009 · Cited by 30
Model systems of genetically modified platelets
Thijs, T., Deckmyn, H., & Broos, K. (2011) · Blood · doi:10.1182/blood-2011-10-381715 · Cited by 28
SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b
Varshney, B., Agnihotram, S., Tan, Y., Baric, R. S., & Lal, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029542 · Cited by 25
“RUNX1 is crucially required for definitive hematopoiesis and Tlymphocyte differentiation [17,18].”
BackgroundPlanagumà, J., González, M., Doll, A., Monge, M., Gil‐Moreno, A., Baró, T., García, Á., Xercavins, J., Alameda, F., Abal, M., et al. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.03.007 · Cited by 23
“Finally, the role of RUNX1/AML1 in coordinating proliferation and differentiation has recently been recognized for the selection of populations of neural progenitors [28], and, indeed, RUNX1/AML1, as a master regulator of hematopoietic systems, is required for megakaryocytic maturation and lymphocytic differentiation…”
BackgroundLoss of RUNX 1/ AML 1 arginine‐methylation impairs peripheral T cell homeostasis
Mizutani, S., Yoshida, T., Zhao, X., Nimer, S. D., Taniwaki, M., & Okuda, T. (2015) · British Journal of Haematology · doi:10.1111/bjh.13499 · Cited by 25
“…self-renewing research paper ª 2015 John Wiley & Sons Ltd British Journal of Haematology, 2015, 170, 859–873 First published online 26 May 2015 doi: 10.1111/bjh.13499 and differentiation of the progenitor cells (Ichikawa et al, 2004; Sun & Downing, 2004; Growney et al, 2005; Putz et al, 2006).”
BackgroundMethodInfluentialHerkt, S. C., Kuvardina, O. N., Herglotz, J., Schneider, L., Meyer, A., Pommerenke, C., Salinas, G., Seifried, E., Bonig, H. B., & Lausen, J. (2017) · Haematologica · doi:10.3324/haematol.2017.174516 · Cited by 30
Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development
Bresciani, E., Carrington, B., Yu, K., Kim, E. M., Zhen, T., Guzman, V. S., Broadbridge, E., Bishop, K. S., Kirby, M., Harper, U. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003969 · Cited by 25
“We believe that elucidating the mechanism of this RUNX1-independent hematopoiesis has far-reaching implications in developing therapeutics for acute myeloid leukemia with germline or somatic mutations in RUNX1.”
BackgroundMouse models for core binding factor leukemia
Chin, D. W. L., Watanabe‐Okochi, N., Wang, C. Q., Tergaonkar, V., & Osato, M. (2015) · Leukemia · doi:10.1038/leu.2015.181 · Cited by 23
Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML
Cammenga, J. (2005) · Leukemia · doi:10.1038/sj.leu.2403894 · Cited by 26
Langebrake, C., Klusmann, J., Wortmann, K., Kolar, M., Puhlmann, U., & Reinhardt, D. (2006) · PubMed · Cited by 27
Ghanem, L. R., Kromer, A., Silverman, I. M., Ji, X., Gazzara, M. R., Nguyen, N., Aguilar, G., Martinelli, M., Barash, Y., & Liebhaber, S. A. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00175-18 · Cited by 19
Thomsen, I., Kunowska, N., de Souza, R. A., Moody, A.-M., Crawford, G., Wang, Y.-F., Khadayate, S. P., Whilding, C., Strid, J., Karimi, M. M., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001367 · Cited by 22
“In addition to its roles in hematopoiesis, RUNX1 also has critical roles in the early stages of T and B cell development (3, 5).”
BackgroundInducible expression of Runx2 results in multiorgan abnormalities in mice
He, N., Xiao, Z., Yin, T., Stubbs, J. R., Li, L., & Quarles, L. D. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22968 · Cited by 21
“…compartments after birth, results in greater impairment of the maturation of megakaryocytes and development of both T and B lymphocytes than myeloid and erythroid development [Wang et al., 662 INDUCIBLE EXPRESSION OF RUNX2 IN VIVO JOURNAL OF CELLULAR BIOCHEMISTRY 1996; Ichikawa et al., 2004a,b].”
BackgroundRoles of RUNX Complexes in Immune Cell Development
Ebihara, T., Seo, W., & Taniuchi, I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_24 · Cited by 22
Transcriptional control of blood cell emergence
Menegatti, S., de Kruijf, M., García-Alegría, E., Lacaud, G., & Kouskoff, V. (2019) · FEBS Letters · doi:10.1002/1873-3468.13585 · Cited by 22
Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription
Beghini, A. (2019) · Cancers · doi:10.3390/cancers11121973 · Cited by 25
Emerging therapies for inv(16) AML
Surapally, S., Tenen, D. G., & Pulikkan, J. A. (2021) · Blood · doi:10.1182/blood.2020009933 · Cited by 25
The inv(16) Cooperates with ARF Haploinsufficiency to Induce Acute Myeloid Leukemia
Moreno–Miralles, I., Pan, L., Keates‐Baleeiro, J., Goodwin, K. D., Yang, C., Kim, H., Thompson, M. A., Klug, C. A., Cleveland, J. L., & Hiebert, S. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506855200 · Cited by 23
Role of the RUNX1‐EVI1 fusion gene in leukemogenesis
Maki, K., Yamagata, T., & Mitani, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00956.x · Cited by 27
Self-citationThe Core Binding Factor CBF Negatively Regulates Skeletal Muscle Terminal Differentiation
Philipot, O., Joliot, V., Aït-Mohamed, O., Pellentz-Lemattre, C., Robin, P., Fritsch, L., & Ait‐Si‐Ali, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009425 · Cited by 22
“[5,6,10] and skin epidermis and hair follicle stem cells [11,12].”
Song, X., Song, Y., Dong, M., Liu, Z., Wang, W., Wang, L., & Song, L. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.03.066 · Cited by 21
Runx1 contributes to neurofibromatosis type 1 neurofibroma formation
Li, H., Zhao, X., Yan, X., Jessen, W. J., Kim, M., Dombi, E., Liu, P. P., Huang, G., & Wu, J. (2015) · Oncogene · doi:10.1038/onc.2015.207 · Cited by 20
The genome-wide molecular signature of transcription factors in leukemia
Prange, K. H. M., Singh, A. A., & Martens, J. H. A. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.04.012 · Cited by 20
Flaumenhaft, R. C., & Sharda, A. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00019-9 · Cited by 38
Widespread presence of bone marrow–like hematopoietic stem cell niche in invertebrate skeletons
Lian, S., Hu, N., Chen, X., Dai, X., Zhu, X., Qiao, R., Liu, S., Lu, Y., Zhang, F., Sun, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw0958 · Cited by 21
Lee, K., Ahn, H.-S., Estevez, B., & Poncz, M. (2022) · Blood · doi:10.1182/blood.2022017561 · Cited by 21
Nagamachi, A., Htun, P. W., Ma, F., Miyazaki, K., Yamasaki, N., Kanno, M., Inaba, T., Honda, Z., Okuda, T., Oda, H., et al. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.07.015 · Cited by 19
“…mice showed a similar phenotype; in the competitive repopulation assay, hematopoietic cells with acquired Runx1 ablation possessed an ability of myeloid differentiation but exhibited almost a complete lack of lymphoid differentiation (Ichikawa et al., 2004; Growney et al., 2005; Putz et al., 2006).”
BackgroundGenua, C. D., Norfo, R., Rodríguez-Meira, A., Wen, W. X., Drissen, R., Booth, C. A. G., Povinelli, B. J., Repapi, E., Gray, N., Carrelha, J., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205351 · Cited by 19
“These results suggest Aml1-ETO affects B and T cell, as well as platelet development, in line with known functions of AML1 (also known as RUNX1).(30,31) K-Ras mutation depletes pre-leukemic HSC”
ResultOrsmark‐Pietras, C., Landberg, N., Lorenz, F., Uggla, B., Höglund, M., Lehmann, S., Derolf, Å. R., Deneberg, S., Antunović, P., Cammenga, J., et al. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22936 · Cited by 19
RUNX3‐mediated repression of RUNX1 in B cells
Brady, G., & Farrell, P. J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21880 · Cited by 24
“Previous studies demonstrated that RUNX1 deletion in adult bone marrow had no effect on the CLP population (Ichikawa et al., 2004) yet this deletion caused a reduced accumulation of cells positive for the universal B-cell marker, B220.”
BackgroundStem cell exhaustion and leukemogenesis
Jacob, B., & Osato, M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22150 · Cited by 23
“However, a series of mouse models designed to recapitulate genetic alterations in human leukemias such as RUNX1-ETO conditional knock-in mice or majority of the Runx1 conditional knockout mice models failed to develop spontaneous leukemia [Higuchi et al., 2002; Ichikawa et al., 2004; Growney et al., 2005].”
BackgroundRegulation of CD4 and CD8 Coreceptor Expression and CD4 Versus CD8 Lineage Decisions
Egawa, T. (2014) · Advances in immunology · doi:10.1016/bs.ai.2014.09.001 · Cited by 24
Differentiation status dependent function of FOG‐1
Tanaka, M., Zheng, J., Kitajima, K., Kita, K., Yoshikawa, H., & Nakano, T. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00796.x · Cited by 21
“For example, recent conditional loss-of-function experiments with transcription factors, such as SCL and Runx-1, have shown that these genes are essential for early development of haematopoiesis but dispensable for adult haematopoiesis (Mikkola et al. 2003; Ichikawa et al. 2004).”
BackgroundSamokhvalov, I. M., Thomson, A. M., Lalancette, C., Liakhovitskaia, A., Ure, J., & Medvinsky, A. (2006) · genesis · doi:10.1002/gene.20190 · Cited by 20
“However, Runx1 is dispensable for maintenance of adult hematopoietic stem cells (HSCs) (Ichikawa et al., 2004).”
Guyot, B., Murai, K., Fujiwara, Y., Valverde-Garduño, V., Hammett, M., Wells, S., Dear, N. T., Orkin, S. H., Porcher, C., & Vyas, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602052200 · Cited by 19
Inherited platelet dysfunction and hematopoietic transcription factor mutations
Songdej, N., & Rao, A. K. (2016) · Platelets · doi:10.1080/09537104.2016.1203400 · Cited by 19
HOXA9 has the hallmarks of a biological switch with implications in blood cancers
Talarmain, L., Clarke, M. A., Shorthouse, D., Cabrera-Cosme, L., Kent, D. G., Fisher, J., & Hall, B. A. (2022) · Nature Communications · doi:10.1038/s41467-022-33189-w · Cited by 19
PDCD2 Controls Hematopoietic Stem Cell Differentiation During Development
Kramer, J., Granier, C. J., Davis, S. A., Piso, K., Hand, J., Rabson, A. B., & Sabaawy, H. E. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0074 · Cited by 19
“In mouse studies, Scl and Runx1 were shown to be necessary for the initiation, but dispensable for the maintenance of HSCs [46].”
BackgroundSasaki, K., Yamagata, T., & Mitani, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00699.x · Cited by 20
Self-citationJablonska, B., Ford, D., Trisler, D. N., & Pessac, B. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2006.06.004 · Cited by 18
“…to be involved in cell cycle and apoptosis, such as Sod-1, an antioxidant enzyme, whose overexpression leads to a hypoplastic thymus and bone marrow abnormalities [10] or the transcription factor Runx1 [11] which codes for AML-1, involved in hematopoiesis regulation and also in DS leukemias [12].”
BackgroundLeong, W. Y., Guo, H. W., Ma, O., Huang, H., Cantor, A. B., & Friedman, A. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.674234 · Cited by 19
The Cell Biology of Stem Cells
Meshorer, E., & Plath, K. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4 · Cited by 23
Helios represses megakaryocyte priming in hematopoietic stem and progenitor cells
Cova, G., Taroni, C., Deau, M.-C., Cai, Q., Mittelheisser, V., Philipps, M., Jung, M., Cerciat, M., Le Gras, S., Thibault-Carpentier, C., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202317 · Cited by 17
Molecular Basis of Hematological Disease Caused by Inherited or Acquired RUNX1 Mutations
Kellaway, S. G., Coleman, D. J. L., Cockerill, P. N., Raghavan, M., & Bonifer, C. (2022) · Experimental Hematology · doi:10.1016/j.exphem.2022.03.009 · Cited by 15
Krivdova, G., Voisin, V., Schoof, E. M., Marhon, S. A., Murison, A., McLeod, J. L., Gabra, M., Zeng, A. G. X., Aigner, S., Yee, B. A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110481 · Cited by 18
Apoptosis in megakaryocytes: Safeguard and threat for thrombopoiesis
Yang, S., Wang, L., Wu, Y., Wu, A., Huang, F., Tang, X., Kantawong, F., Anuchapreeda, S., Qin, D., Mei, Q., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1025945 · Cited by 28
“Previous studies have shown that inducible deletion of RUNX1 in adult mice leads to a rapid and sustained five-fold decrease in peripheral platelet counts (50, 51).”
BackgroundmicroRNA regulation in megakaryocytopoiesis
Li, H., Zhao, H., Wang, D., & Yang, R. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08859.x · Cited by 19
“On the contrary, excision of RUNX1 in adult mice inhibits megakaryocytic maturation, suggesting a 300 ª 2011 Blackwell Publishing Ltd, British Journal of Haematology, 155, 298–307 role in lineage determination (Ichikawa et al, 2004; Growney et al, 2005; Putz et al, 2006).”
BackgroundToya, T., Yoshimi, A., Morioka, T., Arai, S., Ichikawa, M., Usuki, K., & Kurokawa, M. (2013) · Platelets · doi:10.3109/09537104.2013.818636 · Cited by 19
“However, B cell development is also dependent on RUNX1 function [10].”
BackgroundSelf-citationTranscription factors and target genes of pre-TCR signaling
López‐Rodríguez, C., Aramburu, J. F., & Berga-Bolaños, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1864-8 · Cited by 22
“Runx1 (also known as AML1) in bone marrow progenitors causes a blockade of thymocyte development at the DN2 to DN3 transition [65, 66].”
BackgroundOverexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome
Yokomizo‐Nakano, T., Kubota, S., Bai, J., Hamashima, A., Morii, M., Sun, Y., Katagiri, S., Iimori, M., Kanai, A., Tanaka, D., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3167 · Cited by 17
“Runx1 is expressed in HSPCs and its loss impairs normal hematopoiesis, leading to the development of MPN-like disease in vivo, a similar phenotype to that observed in Runx3-deficient mice (5, 14), suggesting a functional redundancy between RUNX1 and RUNX3 for regulating the expression of their common target genes.”
BackgroundLinden, T., Schnittger, S., Groll, A. H., Juergens, H., & Rössig, C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08370.x · Cited by 16
“Both T- and B-lymphocyte development were substantially impaired in RUNX1-deficient murine bone marrow (Ichikawa et al, 2004; Putz et al, 2006).”
BackgroundTranscription factor Runx1 is pro-neurogenic in adult hippocampal precursor cells
Fukui, H., Rünker, A. E., Fabel, K., Buchholz, F., & Kempermann, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190789 · Cited by 18
Liu, H., Carlsson, L., & Grundström, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603249200 · Cited by 21
RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells
Nagai, R., Matsuura, E., Hoshika, Y., Nakata, E., Nagura, H., Watanabe, A., Komatsu, N., Okada, Y., & Doi, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.057 · Cited by 18
Runx1 regulates zebrafish neutrophil maturation via synergistic interaction with c-Myb
Huang, Z., Chen, K., Chi, Y., Jin, H., Li, L., Zhang, W., Xu, J., & Zhang, Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100272 · Cited by 18
“In hematopoiesis, RUNX1 is known to function in the formation of hematopoietic stem cells (12, 31), the fate of macrophages/neutrophils (14), and the maturation of megakaryocytes and lymphocytes (19, 32, 33).”
BackgroundDiscrete regulatory modules instruct hematopoietic lineage commitment and differentiation
Georgolopoulos, G., Psatha, N., Iwata, M., Nishida, A., Som, T., Yiangou, M., Stamatoyannopoulos, J. A., & Vierstra, J. D. (2021) · Nature Communications · doi:10.1038/s41467-021-27159-x · Cited by 22
Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications
Liu, Y.-C., Eldomery, M. K., Maciaszek, J. L., & Klco, J. M. (2025) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023420 · Cited by 16
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
Ochi, Y., & Ogawa, S. (2021) · Cancers · doi:10.3390/cancers13061232 · Cited by 19
Self-citationCore-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter
van der Kouwe, E., Heller, G., Czibere, A. G., Pulikkan, J. A., Agreiter, C., Castilla, L. H., Delwel, R., Ruscio, A. D., Ebralidze, A. K., Forte, M., et al. (2021) · Blood · doi:10.1182/blood.2020008971 · Cited by 18
Takeshita, M., Ichikawa, M., Nitta, E., Goyama, S., Asai, T., Ogawa, S., Chiba, S., & Kurokawa, M. (2008) · Leukemia · doi:10.1038/leu.2008.53 · Cited by 20
Self-citationA retrospective on the requirements for γδ T‐cell development
Hayes, S. M., & Love, P. E. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00476.x · Cited by 19
“(8–12), GATA-3 (13), c-Myb (14), Runx1 (15), guanosine”
Huang, Y.-J., Chen, J., Yan, M., Davis, A. G., Miyauchi, S., Chen, L., Hao, Y., Katz, S., Bejar, R. L., Abdel-Wahab, O. I., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007804 · Cited by 18
Lu, B., Sun, X., Chen, Y., Jin, Q., Liang, Q., Liu, S., Li, Y., Zhou, Y., Li, W., & Huang, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1704-2 · Cited by 18
Okada, Y., Watanabe, M., Nakai, T., Kamikawa, Y., Shimizu, M., Fukuhara, Y., Yonekura, M., Matsuura, E., Hoshika, Y., Nagai, R., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12355 · Cited by 19
RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study
Shen, L., Zhu, J., Chen, F., Lin, W., Cai, J., Zhong, J., & Zhong, H. (2015) · BMC Cancer · doi:10.1186/s12885-015-1961-y · Cited by 17
“However, bone marrow cells of murine transduced with Evi-1 alone cannot cause leukemia [3], while deletion of RUNX1 alone does not immortalize bone marrow cells [4], which suggest that both suppression of RUNX1 and activation of Evi-1 are required for RUNX1-Evi-1 leukemogenesis.”
BackgroundChasing Mavericks: The quest for defining developmental waves of hematopoiesis
Cool, T., & Forsberg, E. C. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.01.001 · Cited by 23
Differential Requirements for Hematopoietic Commitment Between Human and Rhesus Embryonic Stem Cells
Rajesh, D., Chinnasamy, N., Mitalipov, S. M., Wolf, D. P., Slukvin, I. I., Thomson, J. A., & Shaaban, A. F. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0277 · Cited by 15
Metadata
- Authors
- Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., Ogawa, S., & Kurokawa, M.
- Affiliations
- The University of Tokyo (JP)
- Inoue Hospital (JP)
- Joslin Diabetes Center (US)
- Dokkyo University (JP)
- Corresponding author
- Ogawa, Seishi
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-02-15
- Volume
- 10
- Issue
- 3
- Pages
- 299-304
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101518963
- Cited by
- 596
- References
- 29
- Citations by year
- 2026: 11 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 18 · 2019: 22 · 2018: 20 · 2017: 33 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 29 · 2012: 27
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- RUNX1, lymphocyte differentiation, T cell development, B cell development, hematopoietic stem cells, hematopoietic progenitor cells, adult hematopoiesis, myelodysplastic syndrome
- MeSH terms
- Adult, Animals, Bone Marrow Cells, Cell Differentiation, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Lymphocytes, Megakaryocytes, Mice, Inbred Strains, Mice, Transgenic, Proto-Oncogene Proteins, Transcription Factors, Gene Targeting, Cell Lineage, Cell Size, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.